India Lifts Price Ceiling On 174 Drugs, Including Antibiotics, Painkillers
This article was originally published in PharmAsia News
Executive Summary
India's drug-pricing authority has agreed to raise the allowed prices of 174 drugs, including antibiotics, painkillers and drugs for treating asthma, malaria and pneumonia. The National Pharmaceutical Pricing Authority said it had approved the applications of the makers of those and other medicines. The allowed increases range from 1 percent to as much as 33 percent in some cases. The agency said it also fixed the prices of 132 other medicines. (Click here for more
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.